Associate Professor, Oncology, University of Texas Medical School at Houston
Oncology
Dr. Banu K. Arun, MD
|
|
Give Review
Dr. Banu K. Arun works in the field of Oncology. She over the years received 3 awards: "America's Top Doctors", "Top Doctors:SE Texas" and "America's Top Doctors for Cancer". Banu Arun is a published doctor. She has 58 papers published. The most current publication "Examining Mediators and Moderators of Yoga for Women With Breast Cancer Undergoing Radiotherapy." She accepts Medicare.
Publications
- Examining Mediators and Moderators of Yoga for Women With Breast Cancer Undergoing Radiotherapy.
- Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.
- High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative Tumors.
- Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
- Genetic risk assessment for Breast and gynecological malignancies.
- Hereditary breast Cancer syndromes and genetic testing.
- Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
- Clinicopathologic characteristics of breast Cancer in BRCA-carriers and non-carriers in women 35 years of age or less.
- Breast Cancer, BRCA Mutations, and Attitudes Regarding Pregnancy and Preimplantation Genetic Diagnosis.
- Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing.
- Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast Cancer.
- Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast Cancer.
- Characteristics of individuals with breast Cancer rearrangements in BRCA1 and BRCA2.
- Reclassification of predictions for uncovering subgroup specific improvement.
- Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast Cancer risk in non-hispanic white women aged ≤55 years.
- Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary Cancer syndromes.
- Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.
- Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients.
- Simplifying clinical use of the genetic risk prediction model BRCAPRO.
- Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast Cancer.
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
- Outcome of metastatic breast Cancer in selected women with or without deleterious BRCA mutations.
- USP-11 as a Predictive and Prognostic Factor Following Neoadjuvant Therapy in Women With Breast Cancer.
- Genotype in BRCA-associated Breast Cancers.
- Biology, treatment, and outcome in very young and older women with DCIS.
- Invasive paget disease of the Breast: clinicopathologic study of an underrecognized entity in the Breast.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Exemestane in the prevention setting.
- Dose-dense chemotherapy for breast Cancer.
- Assessing the added value of Breast tumor markers in genetic risk prediction model BRCAPRO.
- Aromatase inhibitors and breast Cancer prevention.
- Gamma-ray-induced mutagen sensitivity and risk of sporadic breast Cancer in young women: a case-control study.
- Short -term biomarker modulation prevention study of Anastrozole in Women at increased risk for second primary breast Cancer.
- Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast Cancer: long-term results.
- Earlier age of onset of BRCA mutation-related Cancers in subsequent generations.
- Outcome of triple-negative breast Cancer in patients with or without deleterious BRCA mutations.
- Tamoxifen Downregulates Ets-oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction.
- Early onset HER2-positive breast Cancer is associated with germline TP53 mutations.
- Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for Breast and ovarian carcinoma.
- Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death.
- Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast Cancer.
- Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast Cancer.
- Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹â° p27 phosphorylation in epidermal growth factor receptor-expressing Breast...
- Factors affecting the decision of breast Cancer patients to undergo contralateral prophylactic mastectomy.
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
- Predictors of contralateral breast Cancer in patients with unilateral breast Cancer undergoing contralateral prophylactic mastectomy.
- Accuracy of the BRCAPRO model among women with bilateral breast Cancer.
- Ductal Carcinoma in situ: state of the science and roadmap to advance the field.
- Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast Cancer.
- IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 Breast carcinomas.
- Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast Cancer.
- Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
- A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid Tumors.
- Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in Breast fine-needle aspiration specimens from women at h...
- Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized tr...
- Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.
- The Relationship Between Eight GWAS-Identified Single-Nucleotide Polymorphisms and Primary Breast Cancer Outcomes.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
Education
-
Georgetown University Hospital -
Istanbul University Faculty of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1700971421 | |
| NPPES Provider LastName | ARUN | |
| NPPES Provider FirstName | BANU | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 103.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700971421 |
| Last Name Of The Provider | ARUN |
| First Name Of The Provider | BANU |
| View All |
Similar Doctors
|
|
Dr. Christopher J. Logothetis, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Susan M. Escudier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Musher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padmanee Sharma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Waun K. Hong, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kanwal P. Raghav, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imad Shureiqi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed W. Yusuf, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Vahid Afsharkharghan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio C. Buzaid, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Giora M. Mavligit, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|